AMGN
Amgen Inc.
Company Overview
| Mkt Cap | $160.87B | Price | $298.43 |
| Volume | 2.69M | Change | +2.20% |
| P/E Ratio | 39.3 | Open | $288.46 |
| Revenue | $33.4B | Prev Close | $292.00 |
| Net Income | $4.1B | 52W Range | $253.30 - $335.88 |
| Div Yield | 9.52% | Target | $313.92 |
| Overall | 67 | Value | 80 |
| Quality | -- | Technical | 54 |
No chart data available
Stock Overview
Updated DailyAmgen Inc. (AMGN) is a leading Healthcare company in the Biotechnology industry, currently trading at $298.43 with a market capitalization of $160.87 billion. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows AMGN with a volume of 2.69 million shares. The stock opened down 1.21% from yesterday's close of $292.00. Current analyst estimates project earnings of $21.08 per share for this year, with next year targeting $21.43.
AMGN demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including BMY, PFE, GSK, GILD, ABBV.
Key investment considerations for AMGN include solid overall investment characteristics. The company offers a dividend yield of 9.52% and analyst price targets suggest potential upside of 5.2%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 2, 2025 at 03:47 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMGN | $298.43 | +2.2% | 2.69M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |